Nuclera Ltd
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2013Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
Scanned accounts · read by AI
AI-read
Accounts to 2025-12-31
Scanned accounts · read by AI
- Accounts to
- 2025-12-31
- Filed
- Accounts
- How we read it
- These were filed as scanned pages, so the figures were read by AI and small errors are possible.
Accounts to 2021-12-31
IXBRL · 289 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 289 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 233
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0108_08663936_20211231
- Source archive
- Accounts_Monthly_Data-July2022.zip
Registered details
08663936- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2013-08-27
- Jurisdiction
- —
- Registered office
- ONE VISION PARK, STATION ROAD, CAMBRIDGE, CB24 9NP, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
3 SH01-derived rounds2025-12-02
£9,079,066 raised
£126,201,063 estimated post-money
2022-03-31
£11,688,810 raised
£131,955,152 estimated post-money
2021-12-23
£42,144,196 raised
£111,025,445 estimated post-money
Research and innovation
7 matched grantsA rapid dual screening workflow for membrane protein expression and stabilizationLeadInnovate UK · Collaborative R&D · 2025-08-01 – 2026-07-31 · with 1 other participant£105,000awarded
A rapid dual screening workflow for membrane protein expression and stabilizationLead
Innovate UK · Collaborative R&D · 2025-08-01 – 2026-07-31 · with 1 other participant
£105,000
awarded
Nuclera Ltdlead£105,000
Diamond Light Source£59,988
Developing a mammalian cell-based rapid protein synthesis technology with data-driven capabilities to identify the optimal scale-up conditions for manufactureLeadInnovate UK · Collaborative R&D · 2024-04-01 – 2026-03-31 · with 1 other participant£702,538awarded
Developing a mammalian cell-based rapid protein synthesis technology with data-driven capabilities to identify the optimal scale-up conditions for manufactureLead
Innovate UK · Collaborative R&D · 2024-04-01 – 2026-03-31 · with 1 other participant
£702,538
awarded
Nuclera Ltdlead£702,538
A rapid prototyping device for expression of membrane proteinsLead
Innovate UK · Collaborative R&D · 2024-02-01 – 2025-01-31
£348,756
awarded
Parallelised DNA encoded library screens with Artificial IntelligenceInnovate UK · Collaborative R&D · 2023-11-01 – 2025-09-30 · with 1 other participant£124,858awarded
Parallelised DNA encoded library screens with Artificial Intelligence
Innovate UK · Collaborative R&D · 2023-11-01 – 2025-09-30 · with 1 other participant
£124,858
awarded
Nuclera Ltd£124,858
Development of a next-generation DNA synthesis platformLead
Innovate UK · GRD Development of Prototype · 2015-07-01 – 2016-12-31
£202,913
awarded
Development of a next-generation DNA synthesis platformLead
Innovate UK · GRD Proof of Concept · 2014-07-01 – 2015-06-30
£100,000
awarded
University of Southampton and Nuclera Nucleics LimitedInnovate UK · Knowledge Transfer Partnership · with 1 other participant
University of Southampton and Nuclera Nucleics Limited
Innovate UK · Knowledge Transfer Partnership · with 1 other participant
Nuclera Nucleics Limited—